Bioequivalence Study of NPC-12 (Sirolimus) Granules and Tablets
NCT03765944
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
10
Enrollment
INDUSTRY
Sponsor class
Conditions
Bioequivalence Study
Interventions
DRUG:
sirolimus
Sponsor
Nobelpharma